# Pharmaceutical Industry Canonical URL: https://chemexworld.com/en/categories/sectors/pharmaceutical-industry-1 ## Latest Articles - [Azerbaijan’s Largest Pharmaceutical Plant Commences Operations with Turkish Investment](https://chemexworld.com/en/news/azerbaijans-largest-pharmaceutical-plant-commences-operations-with-turkish-investment.md): Gen Pharma Caucasus Manufacturing Operations, a pharmaceutical manufacturing facility anchored by a 66% majority stake from Turkey’s GEN Pharmaceuticals (GEN İlaç), was officially inaugurated at the Pirallahi Industrial... - [Sanovel Enters Urology with First Sustained-Release Formulation for Overactive Bladder](https://chemexworld.com/en/news/sanovel-enters-urology-with-first-sustained-release-formulation-for-overactive-bladder.md): Sanovel, an established and innovative pharmaceutical company in Turkey, has officially entered the urology therapeutic field with the rollout of its first urological drug as of October 2026. Formulated with the active i... - [Abdi İbrahim Expands European Footprint into North Macedonia](https://chemexworld.com/en/news/abdi-ibrahim-expands-european-footprint-into-north-macedonia.md): Maintaining market leadership in the Turkish pharmaceutical sector for 24 consecutive years, Abdi İbrahim has officially launched its commercial operations in North Macedonia. Unveiled at a corporate launch in Skopje, th... - [Nuvita İlaç, Manufacturing Arm of Orzax, Climbs the Ranks in Turkey R&D 500](https://chemexworld.com/en/news/nuvita-ilac-manufacturing-arm-of-orzax-climbs-the-ranks-in-turkey-rd-500.md): Nuvita İlaç, the strategic manufacturing operations base for Orzax, climbed 17 spots to 231st place among Turkey's highest R&D-spending companies in the Turkey R&D 500 Survey. Increasing its R&D expenditure by 53.8% to T... - [World Medicine Ranks 3rd with 125 Brands in Turkey R&D 500 Survey](https://chemexworld.com/en/news/world-medicine-ranks-3rd-with-125-brands-in-turkey-rd-500-survey.md): Turkey’s pharmaceutical export champion World Medicine secured two major milestones in the Turkey R&D 500 Survey: ranking 3rd overall with 125 registered trademarks and placing 2nd among companies with the highest projec... - [Enterogermina® Launches Enterogermina® Minies to Support Children's Digestive Comfort](https://chemexworld.com/en/news/enterogermina-launches-enterogermina-minies-to-support-childrens-digestive-comfort.md): Opella’s digestive health brand Enterogermina® has introduced its new product, Enterogermina® Minies, engineered to support gut microbiota balance and digestive ease in young children. Formulated with the clinically stud... - [Orzax Sustains Growth in the First Half of 2026](https://chemexworld.com/en/news/orzax-sustains-growth-in-the-first-half-of-2026.md): Food supplement manufacturer Orzax disclosed its first post-IPO financial results for the first half of 2026. The company increased its revenue by 36% year-on-year to TL 4.5 billion (TL 4,525,914,424) and expanded its ne... - [Abdi İbrahim’s Future Explorers Program Enters Its 5th Year](https://chemexworld.com/en/news/abdi-ibrahims-future-explorers-program-enters-its-5th-year.md): Run in collaboration with Bilim Virüsü, Abdi İbrahim’s Future Explorers Program enters its fifth year. Designed for high school students aged 15–18 across Turkey, applications for the first module of the free online scie... - [Strategic Partnership Agreement Signed Between Gürel İlaç and Ribogen İlaç](https://chemexworld.com/en/news/strategic-partnership-agreement-signed-between-gurel-ilac-and-ribogen-ilac.md): Gürel İlaç and Ribogen İlaç have signed a strategic collaboration agreement in the Turkish pharmaceutical sector. Under the agreement executed on July 3, 2026, the sales, marketing, and distribution rights for two produc... - [Sanovel Strengthens Global Position with International Investments](https://chemexworld.com/en/news/sanovel-strengthens-global-position-with-international-investments.md): Sanovel CEO Hülya Yalın detailed the company's export operations across 50 countries supported by its Silivri R&D base. Investing $26 million in facility equipment over the last 5 years, Sanovel aims to double its footpr... - [Major Production Expansion in Central Asia by Orzax](https://chemexworld.com/en/news/major-production-expansion-in-central-asia-by-orzax.md): Turkish food supplement brand Orzax has broken ground on its new GMP-compliant manufacturing facility in Kazakhstan's Turkistan "TURAN" Special Economic Zone. Built with a $40 million investment, the facility targets an... - [Abdi İbrahim Earns First Equal Pay Certification in Turkish Pharma Industry](https://chemexworld.com/en/news/abdi-ibrahim-earns-first-equal-pay-certification-in-turkish-pharma-industry.md): Abdi İbrahim has been awarded the Equal Pay certification by the EQUAL-SALARY Foundation, recognizing its equal remuneration practices for men and women performing equal work. The company becomes the first in the Turkish... - [Santa Farma and KOÜ Launch Turkey's First Pharma Production Tech Program](https://chemexworld.com/en/news/santa-farma-and-kou-launch-turkeys-first-pharma-production-tech-program.md): Santa Farma Pharma and Kocaeli University have established Turkey's first "Pharmaceutical Production Technology" associate degree program following YÖK approval. Utilizing an on-the-job training model, the curriculum pre... - [Double Approval from Eurasia for Santa Farma's Manufacturing Facility](https://chemexworld.com/en/news/double-approval-from-eurasia-for-santa-farmas-manufacturing-facility.md): Santa Farma Pharma's manufacturing plant in Kocaeli-GEBKİM has successfully completed GMP (Good Manufacturing Practices) audits conducted by health authorities in Russia and Kazakhstan, both members of the Eurasian Econo... - [Biofarma Pharma Appoints Çiğdem Sayın as Sales, Marketing, and Medical Director!](https://chemexworld.com/en/news/biofarma-pharma-appoints-cigdem-sayin-as-sales-marketing-and-medical-director.md): Biofarma Pharma has permanently appointed Çiğdem Sayın as its Sales, Marketing, and Medical Director, a role she had held on an acting basis since January 2026. Bringing over 20 years of pharmaceutical expertise, Sayın w... - [Executive Appointment at Biofarma Pharma: Pharm. Gözde Terkan Appointed as CEO](https://chemexworld.com/en/news/executive-appointment-at-biofarma-pharma-pharm-gozde-terkan-appointed-as-ceo.md): Biofarma Pharma, one of the established manufacturers in the Turkish pharmaceutical sector, has announced an executive leadership transition. Pharm. Gözde Terkan, who served as Sales, Marketing, and Medical Director and... - [Abdi İbrahim Wins Gold Stevie Award for Blue-Collar HR Transformation](https://chemexworld.com/en/news/abdi-ibrahim-wins-gold-stevie-award-for-blue-collar-hr-transformation.md): Abdi İbrahim has been awarded the Gold Stevie at the Stevie Awards for Great Employers for its "Blue-Collar Skill-Based Compensation Design" project, which reflects production operators' technical expertise and experienc... - [The Bell Rings for Orzax at Borsa Istanbul](https://chemexworld.com/en/news/the-bell-rings-for-orzax-at-borsa-istanbul.md): Having drawn immense investor demand during the bookbuilding phase, nutraceutical manufacturer Orzax successfully completed its initial public offering (IPO) and began trading on Borsa Istanbul's Stars Market under the t... - [Nobel İlaç Restructures Its Sales and Marketing Division Under Internal Leaders](https://chemexworld.com/en/news/nobel-ilac-restructures-its-sales-and-marketing-division-under-internal-leaders.md): Nobel İlaç has restructured its domestic Sales and Marketing organization to align with its strategic growth targets. Previously managed under two separate divisions, the activities have been consolidated into four prima... - [Orzax Finalizes IPO with a Total Volume of TRY 3.6 Billion](https://chemexworld.com/en/news/orzax-finalizes-ipo-with-a-total-volume-of-try-36-billion.md): Dietary supplement manufacturer Orzax has successfully finalized its initial public offering (IPO) bookbuilding process. Spearheaded by consortium leader İnfo Yatırım, the total IPO size reached 3,622,500,000 TRY. The co... - [Santa Farma Pharma Rises 15 Places in the ISO 500 Rankings](https://chemexworld.com/en/news/santa-farma-pharma-rises-15-places-in-the-iso-500-rankings.md): Santa Farma Pharmaceuticals, one of the deeply rooted actors in the Turkish pharmaceutical industry, has maintained its position on the "Top 500 Industrial Enterprises of Turkey" list announced by the Istanbul Chamber of... - [World Medicine Scales to 318th in Turkey’s Top 500 Industrial Enterprises Index](https://chemexworld.com/en/news/world-medicine-scales-to-318th-in-turkeys-top-500-industrial-enterprises-index.md): Advancing 24 positions to rank 318th in the ISO 500 listings, World Medicine has officially validated its continuous scaling across the global healthcare market. - [Toros Ecza Joins Albar Group](https://chemexworld.com/en/news/toros-ecza-joins-albar-group.md): Toros Ecza ve Kimyevi Maddeler, a veteran player in the chemical and laboratory supply sector since 1952, has officially announced its acquisition by the Albar Group. The company aims to carry its 74-year legacy into the... - [Abdi İbrahim Secures 200 New Commercial Field Assets to Reinforce Market Leadership](https://chemexworld.com/en/news/abdi-ibrahim-secures-200-new-commercial-field-assets-to-reinforce-market-leadership.md): Holding its position as Turkey’s premier pharmaceutical enterprise for 24 consecutive years, Abdi İbrahim deployed a nationwide recruitment campaign to onboard 200 Medical Sales Representatives, driving multi-channel cov... - [Gökdeniz Gür Appointed CFO of Sanovel](https://chemexworld.com/en/news/gokdeniz-gur-appointed-cfo-of-sanovel.md): Strengthening its corporate governance framework to drive transcontinental expansion, major Turkish pharmaceutical manufacturer Sanovel has named retail financial expert Gökdeniz Gür as its new Chief Financial Officer. - [GEN Commences Phase II Clinical Trial for Hibernation-Inspired Parkinson’s Molecule "SUL-238"](https://chemexworld.com/en/news/gen-commences-phase-ii-clinical-trial-for-hibernation-inspired-parkinsons-molecule-sul-238.md): Partnering with Netherlands-based Sulfateq BV, GEN (GENIL.IS) announced that the first patient has been dosed in the Phase II SHEPHERD proof-of-concept study. The trial leverages Magnetic Resonance Spectroscopy ($^{31}\t... - [Abdi İbrahim Commences Digital and Green Transition via QR-Coded Electronic Instructions for Use](https://chemexworld.com/en/news/abdi-ibrahim-commences-digital-and-green-transition-via-qr-coded-electronic-instructions-for-use.md): Aligning its secondary packaging assets with official regulatory updates ahead of schedule, Abdi İbrahim has rolled out its inaugural pharmaceutical batches featuring electronic instructions (e-IFU). The transition targe... - [Humanis Launches "PAHCase" Platform for Pulmonary Hypertension](https://chemexworld.com/en/news/humanis-launches-pahcase-platform-for-pulmonary-hypertension.md): Introducing a new paradigm in medical communications, Humanis presented its interactive case simulation and medical council network, PAHCase, designed specifically for physicians working in the field of pulmonary vascula... - [Santa Farma Pharmaceutical Solidifies R&D Leadership:](https://chemexworld.com/en/news/santa-farma-pharmaceutical-solidifies-rd-leadership.md): With over 80 years of deep-rooted experience in the pharmaceutical sector, Santa Farma Pharmaceutical has demonstrated its robust R&D performance by ranking near the top of three distinct categories in Patent Effect's "T... - [Diplomatic Support for Turkish Brands in the U.S. Market](https://chemexworld.com/en/news/diplomatic-support-for-turkish-brands-in-the-us-market.md): As demand for natural products, wellness solutions and dietary supplements continues to grow in the U.S., Turkish brands are strengthening their visibility in the market. Within this scope, T.C. Chicago Consul General Ta...